Cargando…

Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway

BACKGROUND: Therapeutic hypothermia is a treatment modality that is increasingly used to improve clinical neurological outcomes for ischemia-reperfusion injury-mediated diseases. Antibody-initiated classical complement pathway activation has been shown to contribute to ischemia-reperfusion injury in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Tushar A, Mauriello, Clifford T, Hair, Pamela S, Sandhu, Amandeep, Stolz, Michael P, Bass, William Thomas, Krishna, Neel K, Cunnion, Kenji M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079622/ https://www.ncbi.nlm.nih.gov/pubmed/24962100 http://dx.doi.org/10.1186/1479-5876-12-181

Ejemplares similares

Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
por: Kumar, Parvathi, et al.
Publicado: (2021)

Hyperglycemia Inhibits Complement-Mediated Immunological Control of S. aureus in a Rat Model of Peritonitis
por: Mauriello, Clifford T., et al.
Publicado: (2014)

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin
por: Hair, Pamela S., et al.
Publicado: (2017)

Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
por: Hair, Pamela S., et al.
Publicado: (2018)

Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease
por: Sass, Laura A., et al.
Publicado: (2015)

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity
por: Hair, Pamela S., et al.
Publicado: (2017)

Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019)

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017)

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)
por: Gregory Rivera, Magdielis, et al.
Publicado: (2018)

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report
por: Hair, Pamela S., et al.
Publicado: (2021)

Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)

Therapeutic Hypothermia Inhibits the Classical Complement Pathway in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy
por: Shah, Tushar A., et al.
Publicado: (2021)

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats
por: Sharp, Julia A., et al.
Publicado: (2015)

Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice
por: Bhutta, Maimoona S., et al.
Publicado: (2021)

Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes
por: Enos, Adrianne, et al.
Publicado: (2021)

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus
por: Hair, Pamela S, et al.
Publicado: (2012)

Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds
por: Cunnion, Kenji M., et al.
Publicado: (2017)

Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)
por: Cunnion, Kenji M., et al.
Publicado: (2019)

Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies
por: Krishna, Neel K., et al.
Publicado: (2012)

An 11-Year-Old Male with Refractory Osteomyelitis
por: Mauriello, Clifford T., et al.
Publicado: (2012)

Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic
por: Sharp, Julia A., et al.
Publicado: (2012)

The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy
por: Krishna, Neel K., et al.
Publicado: (2022)

RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101
por: Goss, Jessica M., et al.
Publicado: (2023)

997. RLS-0071 Improves Survival in a Rat Model of Intestinal Necrosis
por: Cunnion, Kenji, et al.
Publicado: (2021)

Incompatible erythrocyte transfusion with lipopolysaccharide induces acute lung injury in a novel rat model
por: Gregory Rivera, Magdielis, et al.
Publicado: (2020)

Peptide inhibition of acute lung injury in a novel two-hit rat model
por: Sampson, Alana C., et al.
Publicado: (2021)

Non-classical monocytes as mediators of tissue destruction in arthritis
por: Puchner, Antonia, et al.
Publicado: (2018)

Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components
Publicado: (1989)

Antibody-independent complement activation by myelin via the classical complement pathway
Publicado: (1982)

Diffusion Dynamics and Creative Destruction in a Simple Classical Model
por: Haas, David
Publicado: (2015)

Evidence for classic complement activity in neuromyelitis optica
por: Jones, Melina V., et al.
Publicado: (2014)

Complement activated granulocytes can cause autologous tissue destruction in man
por: Löhde, E., et al.
Publicado: (1992)

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway
por: Mutti, Michele, et al.
Publicado: (2018)

Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
por: Gregersen, Emil, et al.
Publicado: (2021)

Continual Low-Level Activation of the Classical Complement Pathway
por: Manderson, Anthony P., et al.
Publicado: (2001)

Activation of the classical pathway of complement by Hageman factor fragment
Publicado: (1981)

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway
por: Koro, Catalin, et al.
Publicado: (2014)

Preanalytical classical and alternative complement pathway activity loss
por: Vercauteren, Koen O.A., et al.
Publicado: (2019)

SERUM-MEDIATED LEUKEMIA CELL DESTRUCTION IN AKR MICE : ROLE OF COMPLEMENT IN THE PHENOMENON
por: Kassel, Robert L., et al.
Publicado: (1973)

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction
por: Milde, Ronny, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4skl9gujdrf5bh6n88cl9bkpav